Back
Perspective Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.21
Seasonality Move:
27.93%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.52 | Sell |
| 20-day SMA: | 3.98 | Sell |
| 50-day SMA: | 8.6 | Sell |
| 200-day SMA: | 12.31 | Sell |
| 8-day EMA: | 3.52 | Sell |
| 20-day EMA: | 4.66 | Sell |
| 50-day EMA: | 7.49 | Sell |
| 200-day EMA: | 10.23 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.53 | Sell |
| Relative Strength Index (14 RSI): | 20.31 | Sell |
| Chaikin Money Flow: | -1528174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.76 - 7.16) | Sell |
| Bollinger Bands (100): | (7.26 - 15.12) | Sell |
Perspective Therapeutics Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 3.07 while CATX 8-day simple moving average is 3.52, which is a Sell signal.
- The stock price of CATX is 3.07 while Perspective Therapeutics 20-day SMA is 3.98, which makes it a Sell.
- Perspective Therapeutics 50-day simple moving average is 8.60 while CATX share price is 3.07, making it a Sell technically.
- CATX stock price is 3.07 and Perspective Therapeutics 200-day simple moving average is 12.31, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $3.07. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
207.49M
Price in USD:
3.07
Share Volume:
1.53M
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.60
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 3.07 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 3.07 while CATX 8-day exponential moving average is 3.52, which is a Sell signal.
- The stock price of CATX is 3.07 while Perspective Therapeutics 20-day EMA is 4.66, which makes it a Sell.
- Perspective Therapeutics 50-day exponential moving average is 7.49 while CATX share price is 3.07, making it a Sell technically.
- CATX stock price is 3.07 and Perspective Therapeutics 200-day simple moving average is 10.23, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is -1.53, suggesting Perspective Therapeutics is a Sell
- Perspective Therapeutics Relative Strength Index (RSI) is 20.31, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (2.76 - 7.16), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (7.26 - 15.12), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.